Recro Pharma Inc reports results for the quarter ended in June - Earnings Summary

Societal CDMO

10/08/2021 24:55

* Recro Pharma Inc  REPH.OQ  reported quarterly adjusted
earnings of 3 cents​​ per share for the quarter ended in June.
The mean expectation of two analysts for the quarter was for a
loss of 11 cents per share.
* Revenue rose 16.1% to $18.02 million from a year ago; 
analysts expected $17.10 million. 
* Recro Pharma Inc's reported EPS for the quarter was 3 cents​.
* The mean earnings estimate of analysts had risen by about 8.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Recro Pharma Inc shares had fallen by 18.2% this quarter and
lost 33.7% so far this year.
* The company reported quarterly net income of $1.23 million.
* Wall Street's median 12-month price target for Recro Pharma
Inc is $5.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 11:54 p.m.  ​All
figures in US dollars unless otherwise stated